Events Calendar

Print

Please use the drop-down menus to refine your search:

JCCC Research Seminar featuring Roger Slavik

The Ahmanson Biomedical Cyclotron Facility and its role in optimizing targeted radioligand therapy

Presented by
Roger Slavik, Ph.D.
Assistant Professor, Molecular and Medical Pharmacology Director, Ahmanson Biomedical Cyclotron Facility

Dr. Roger Salvik’s research focuses on the development of theranostics for the diagnosis and treatment of cancer and the synthesis of novel potential PET probes for use as cancer biomarkers. He is the director of the Ahmanson Biomedical Cyclotron Facility, which manufactures a variety of PET ligands for clinical service and synthesizes probes for clinical and preclinical research.

Light lunch served


Sponsored by the UCLA Jonsson Comprehensive Cancer Center Cancer Molecular Imaging, Nanotechnology and Theranostics Program

Return to full list >>